2Weidtmann B, Schunkert H. Uremia and cardiovascular disease. Internist, 2007 ; 48 (8) : 770 - 778
3Mall G. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant, 1990; 5:39 -44
4Gross ML, Ritz E. Hypertrophy and fibrosis in the cardiomyopathy of uremia - - beyond coronary heart disease. Semin Dial, 2008; 21 (4): 308-318
5Amann K, Buzello M, Simonnaviciene A. Capillary/myocyle mismatch in the heart in renal failure - a role for erythropoietin ? Nephrol Dial Transplant, 2000; 15 (7) : 96
6Ansari , Vemejoui MC, Fabiani F. Secondary hypertrophy in hemodialysis patients. Kidney Int, 1997; 32 -33
7Nayak SG, Satisk R. An unusual toxic cause of hemolytic -uremic syndrome. J Toxicol Sci, 2007, 32 (2) : 197 - 199
8Amann K, Ritz E, Wiest Get al. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J An See Mphml, 1994; 4 (10) : 1814-1819
9Hara S, Ubara Y, Arimno K. Relation between parathyroid hormone and cardiac function in long - term hemodialysis patients. Miner Electrolyte Nbtab, 1995; 21 ( 1 - 3) : 72 - 76
10Paolo R, Boulay A, Chasan - Taber Set al. Cardiac calcification in adult hemodialysis patients: A link between end - stage renal disase and cardiovascular disease. J Am Call Cardiol, 2002; 39 (4): 695- 701
